GSK3B and early-onset autosomal dominant Alzheimer disease: Interacts with Axin, APC, and β‐catenin; identified as target of Wnt agonist/IQ and sodium selenite; activates WβC‐AC via increased activation of β‐catenin and decreased GSK‐3β levels in a triple transgenic mouse model of Alzheimer's disease